Evidence map›Paper›PMID 42138484›Full record

ArticleCancer reports (Hoboken, N.J.)2026

A Rare Case of Primary Pulmonary Choriocarcinoma Metastasizing to the Kidney: Diagnostic and Therapeutic Complexities.

Zorán Belics, Antónia Fürich, Levente Bogyó, Hanna Tihanyi, Mária Madarász, Dorottya Rózsa, Gizella Molnár, Balázs Gérecz, Petronella Hupuczi

Abstract readCase Reports
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zorán BelicsSzéchenyi István University, Győr, Hungary.ORCID 0000-0001-8220-3511
Antónia FürichMaternity Private Department of Obstetrics and Gynecology, Budapest, Hungary.ORCID 0009-0004-9117-5048
Levente BogyóDepartment of Thoracic Surgery, National Oncology Institute, Budapest, Hungary.ORCID 0000-0003-1207-2258
Hanna TihanyiDepartment of Thoracic Surgery, National Oncology Institute, Budapest, Hungary.ORCID 0009-0003-4409-9217
Mária MadarászMaternity Private Department of Obstetrics and Gynecology, Budapest, Hungary.ORCID 0009-0006-0392-8025
Dorottya RózsaMaternity Private Department of Obstetrics and Gynecology, Budapest, Hungary.ORCID 0009-0005-4107-9784
Gizella MolnárMaternity Private Department of Obstetrics and Gynecology, Budapest, Hungary.ORCID 0009-0008-8272-2627
Balázs GéreczMaternity Private Department of Obstetrics and Gynecology, Budapest, Hungary.ORCID 0009-0002-7667-3837
Petronella HupucziMaternity Private Department of Obstetrics and Gynecology, Budapest, Hungary.ORCID 0000-0002-1267-7364

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChoriocarcinoma is a highly aggressive malignant tumor composed primarily of cytotrophoblast and syncytiotrophoblast cells without villi and is characterized by beta-human chorionic (beta-hCG) gonadotropin production. Although most cases are of gestational origin, rare non-gestational choriocarcinomas may arise from pluripotent germ cells in extragenital locations, independently of pregnancy. Primary pulmonary choriocarcinoma is extremely rare, and kidney metastasis has only exceptionally been reported in the literature. CASE: We present the case of a 43-year-old patient with this unusual presentation. The diagnostic process began with a suspected implantation of unknown location and culminated in the final histopathological diagnosis based on lobectomy and nephrectomy specimens, including molecular genetic identification of the pulmonary tumor. Following thoracic and renal surgery, the patient received adjuvant chemotherapy and immunotherapy with anti-PD-1 monoclonal antibodies.

conclusionThis case highlighted the diagnostic challenges posed by primary pulmonary choriocarcinoma with renal metastasis, an exceptionally rare clinical entity. Ongoing follow-up includes regular imaging studies and beta-hCG monitoring.

Indexed as

ChoriocarcinomaChoriocarcinoma, Non-gestationalKidney NeoplasmsLung NeoplasmsAdultChemotherapy, AdjuvantFemaleHumansImmune Checkpoint InhibitorsNephrectomyPneumonectomyPregnancyImmune Checkpoint Inhibitorsbeta‐hCGchemotherapygestational trophoblastic diseaseimmunotherapyprimary pulmonary choriocarcinomarenal metastasis

Identifiers

PMID42138484
PMCPMC13178143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.